- Home
- BACK vs WINT Comparison
BACK vs WINT Comparison
Compare BACK & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BACK
- WINT
- Stock Information
- Founded
- BACK 2000
- WINT 1992
- Country
- BACK United States
- WINT United States
- Employees
- BACK N/A
- WINT 20
- Industry
- BACK Medical Specialities
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BACK Health Care
- WINT Health Care
- Exchange
- BACK Nasdaq
- WINT Nasdaq
- Market Cap
- BACK 2.2M
- WINT 2.0M
- IPO Year
- BACK 2019
- WINT 1995
- Fundamental
- Price
- BACK $1.32
- WINT $0.22
- Analyst Decision
- BACK
- WINT Hold
- Analyst Count
- BACK 0
- WINT 1
- Target Price
- BACK N/A
- WINT $7.00
- AVG Volume (30 Days)
- BACK 50.3K
- WINT 4.0M
- Earning Date
- BACK 01-28-2025
- WINT 11-27-2024
- Dividend Yield
- BACK N/A
- WINT N/A
- EPS Growth
- BACK N/A
- WINT N/A
- EPS
- BACK N/A
- WINT N/A
- Revenue
- BACK N/A
- WINT N/A
- Revenue This Year
- BACK N/A
- WINT N/A
- Revenue Next Year
- BACK N/A
- WINT N/A
- P/E Ratio
- BACK N/A
- WINT N/A
- Revenue Growth
- BACK N/A
- WINT N/A
- 52 Week Low
- BACK $0.98
- WINT $0.21
- 52 Week High
- BACK $7.75
- WINT $14.75
- Technical
- Relative Strength Index (RSI)
- BACK 55.65
- WINT 24.72
- Support Level
- BACK $1.16
- WINT $0.21
- Resistance Level
- BACK $1.45
- WINT $0.27
- Average True Range (ATR)
- BACK 0.12
- WINT 0.04
- MACD
- BACK -0.00
- WINT 0.01
- Stochastic Oscillator
- BACK 55.17
- WINT 4.79
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.